Quoin Pharmaceuticals Management
Management criteria checks 3/4
Quoin Pharmaceuticals' CEO is Michael Myers, appointed in Mar 2018, has a tenure of 6.67 years. total yearly compensation is $1.26M, comprised of 48% salary and 52% bonuses, including company stock and options. directly owns 0.94% of the company’s shares, worth $29.30K. The average tenure of the management team and the board of directors is 6.7 years and 3.1 years respectively.
Key information
Michael Myers
Chief executive officer
US$1.3m
Total compensation
| CEO salary percentage | 48.0% |
| CEO tenure | 6.7yrs |
| CEO ownership | 0.9% |
| Management average tenure | 6.7yrs |
| Board average tenure | 3.1yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$9m |
| Jun 30 2024 | n/a | n/a | -US$8m |
| Mar 31 2024 | n/a | n/a | -US$8m |
| Dec 31 2023 | US$1m | US$602k | -US$9m |
| Sep 30 2023 | n/a | n/a | -US$9m |
| Jun 30 2023 | n/a | n/a | -US$10m |
| Mar 31 2023 | n/a | n/a | -US$10m |
| Dec 31 2022 | US$2m | US$550k | -US$9m |
| Sep 30 2022 | n/a | n/a | -US$19m |
| Jun 30 2022 | n/a | n/a | -US$18m |
| Mar 31 2022 | n/a | n/a | -US$19m |
| Dec 31 2021 | US$1m | US$519k | -US$21m |
| Sep 30 2021 | n/a | n/a | -US$11m |
| Jun 30 2021 | n/a | n/a | -US$10m |
| Mar 31 2021 | n/a | n/a | -US$6m |
| Dec 31 2020 | US$579k | US$500k | -US$2m |
Compensation vs Market: Michael's total compensation ($USD1.26M) is above average for companies of similar size in the US market ($USD652.28K).
Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.
CEO
Michael Myers (62 yo)
6.7yrs
Tenure
US$1,255,188
Compensation
Dr. Michael Myers, Ph D., has been an Independent Director at Squarex Pharmaceutical Corp., since November 2022. He serves as Chief Executive Officer and Chairman of Quoin Pharmaceuticals, Ltd.from Octobe...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 6.7yrs | US$1.26m | 0.94% $ 29.3k | |
| Co-Founder | 6.7yrs | US$1.07m | 0.93% $ 29.2k | |
| Chief Financial Officer | 3yrs | US$775.94k | 0.57% $ 17.9k |
6.7yrs
Average Tenure
60yo
Average Age
Experienced Management: QNRX's management team is seasoned and experienced (6.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 3.1yrs | US$1.26m | 0.94% $ 29.3k | |
| Co-Founder | 3.1yrs | US$1.07m | 0.93% $ 29.2k | |
| Independent Director | 3.1yrs | US$107.62k | 0% $ 0 | |
| Independent Director | 3.1yrs | US$112.62k | 0% $ 0 | |
| Independent Director | 3.1yrs | US$117.62k | 0.0010% $ 32.9 | |
| Independent Director | 3.1yrs | US$122.62k | 0.0063% $ 196.6 | |
| Independent Director | 3.1yrs | US$122.62k | 0% $ 0 | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | no data | no data | no data |
3.1yrs
Average Tenure
66yo
Average Age
Experienced Board: QNRX's board of directors are considered experienced (3.1 years average tenure).